サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1529872

創薬における人工知能の市場規模、シェア、動向分析レポート：治療分野別、用途別、地域別、セグメント予測、2024年～2030年

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Therapeutic Space (Oncology, Neurodegenerative Diseases), By Application, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 80 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
創薬における人工知能の市場規模、シェア、動向分析レポート：治療分野別、用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年07月26日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

創薬における人工知能市場の成長と動向：

創薬における人工知能の世界市場規模は2030年に91億米ドルと推計され、2024年から2030年までCAGR 29.7%で拡大すると予測されます。

2023年から2030年までのCAGRは29.6%で拡大する見込みです。パンデミックにより、製薬業界ではAIの導入が広がっています。AIとその関連プラットフォームは、医療画像と診断、慢性疾患の管理、薬剤設計を強化することを目指しています。同じデータをスキャンするAIシステムに比べ、人間が費やす時間は圧倒的に多くなるため、全体的なコストが削減され、より実現可能なアプローチとなります。

薬剤最適化・再利用アプリケーション分野は、2022年に最大の収益シェアを占めました。AIプラットフォームは、薬剤の有害事象や副作用の可能性を判断するために、薬剤の標的タンパク質の同定に役立ちます。薬剤分子は、より効果的で副作用を最小限にするために再利用することができます。企業のポートフォリオ薬剤は、新薬開発を早めるため、AIプラットフォームを使用することで、より速いペースで変更・研究することができます。

2022年には、がん治療領域セグメントが最大の収益シェアを占めました。製薬会社の大半は、AI新興企業と提携してがん研究を最適化しているが、これはまだ未知の領域であり、発見すべきことがたくさんあります。AIシステムは、徹底的に訓練された放射線科医でさえ、通常のスキャンが示すよりもはるかに早い段階でがんを特定することができます。その結果、寿命が延び、がん研究や医薬品開発のために調査すべきマーカーを特定することもできます。患者は自分の遺伝子構成に適した治療を処方されます。

2022年の市場は北米が独占しました。現在、多くのハイテク企業が、製薬会社におけるAIの活用に向けて資金と努力を投じています。IBM、マイクロソフト、その他のハイテク大手のような企業は、複数の適応症に対するより迅速な医薬品開発と臨床試験のために研究機関と協力関係を結んでいます。新興諸国もまた、薬剤開発と疾患理解のためにAI技術を導入する費用対効果の高い方策を見出しつつあります。

創薬における人工知能市場レポートハイライト

  • 薬剤の最適化と再利用の用途分野が市場を独占し、2022年の収益シェアは53.9%超を占めました。
  • 治療分野別では、がん領域が2022年に23.4%超の最大の収益シェアを占めました。感染症分野は予測期間中に最も速い成長率を記録すると予想されます。
  • アジア太平洋地域は、2023年から2030年にかけて最も速いCAGRで拡大すると予想されています。これは、疾患を理解し創薬を支援する手段として、この地域の新興諸国がAIの採用を増やしていることに起因しています。
  • 北米は市場をリードし、2022年の収益シェアは58.0%を超えました。米国は人工知能技術の先駆者であり、この地域の市場成長に大きく貢献しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の創薬における人工知能（AI）市場の変数、動向、範囲

  • 市場セグメンテーション
  • 創薬市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 世界の創薬における人工知能（AI）市場：PESTLE分析
    • 世界の創薬における人工知能（AI）市場：ポーターの分析

第4章 世界の創薬における人工知能（AI）市場：用途別推定・動向分析

  • 創薬における人工知能（AI）市場：用途別変動分析
  • 医薬品の最適化と再利用
  • 前臨床試験
  • その他の用途

第5章 世界の創薬における人工知能（AI）市場：治療分野別推定・動向分析

  • 創薬における人工知能（AI）市場：治療分野別変動分析
  • 腫瘍学
  • 神経変性疾患
  • 心血管疾患
  • 代謝性疾患
  • 感染症
  • その他

第6章 世界の創薬における人工知能（AI）市場：地域別推定・動向分析

  • 世界の創薬における人工知能（AI）市場：地域別動向分析
  • 世界の創薬における人工知能（AI）市場シェア、地域別、2021年および2030年
  • 北米
    • 北米人工知能
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州人工知能
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • デンマーク
  • アジア太平洋
    • アジア太平洋人工知能
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカの人工知能
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ人工知能
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合分析

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類（主要なイノベーター、市場リーダー、新興企業）
  • 競合ダッシュボードと企業の市況分析
    • シナジー分析：主要取引と戦略的提携
    • 主要な新興企業/ テクノロジーの破壊者/ イノベーターのリスト

第8章 競合情勢

  • IBM
    • 会社概要
    • 財務実績
    • 提供品
    • 戦略的取り組み
  • Exscientia
    • 会社概要
    • 財務実績
    • 提供品
    • 戦略的取り組み
  • GNS Healthcare（In January 2023, the company Rebranded as Aitia）
    • 会社概要
    • 財務実績
    • 提供品
    • 戦略的取り組み
  • Google（DeepMind）
    • 会社概要
    • 財務実績
    • 提供品
    • 戦略的取り組み
  • BenevolentAI
    • 会社概要
    • 財務実績
    • 提供品
    • 戦略的取り組み
  • BioSymetrics, Inc
    • 会社概要
    • 財務実績
    • 提供品
    • 戦略的取り組み
  • Atomwise Inc.
    • 会社概要
    • 財務実績
    • 提供品
    • 戦略的取り組み
  • Berg Health（In January 2023, BPGbio Inc. acquired Berg Health）
    • 会社概要
    • 財務実績
    • 提供品
    • 戦略的取り組み
  • insitro
    • 会社概要
    • 財務実績
    • 提供品
    • 戦略的取り組み
  • CYCLICA（In May 2023, CYCLICA acquired by Recursion）
    • 会社概要
    • 財務実績
    • 提供品
    • 戦略的取り組み
図表

List of Tables

  • Table 1 Partial list of secondary sources
  • Table 2 North America Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 4 U.S. Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 6 Canada Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 8 Mexico Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 10 Europe Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 11 Europe Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 12 UK Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 13 UK Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 14 Germany Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 15 Germany Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 16 France Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 17 France Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 18 Spain Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 19 Spain Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 20 Italy Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 21 Italy Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 22 Denmark Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 23 Denmark Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 24 Sweden Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 25 Sweden Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 26 Norway Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 27 Norway Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 30 China Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 31 China Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 32 India Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 33 India Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 34 Japan Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 35 Japan Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 36 Australia Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 37 Australia Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 38 South Korea Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 39 South Korea Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 40 Latin America Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 41 Latin America Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 42 Brazil Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 43 Brazil Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 44 Argentina Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 45 Argentina Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 46 Middle East & Africa Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 47 Middle East & Africa Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 48 South Africa Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 49 South Africa Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 50 Saudi Arabia Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 51 Saudi Arabia Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 52 UAE Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 53 UAE Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 54 Kuwait Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
  • Table 55 Kuwait Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Global Artificial Intelligence in drug discovery market snapshot, 2021 (USD Million)
  • Fig. 9 Global Artificial Intelligence in drug discovery market segmentation
  • Fig. 10 Global Artificial Intelligence in drug discovery market dynamics
  • Fig. 11 Global Artificial Intelligence in drug discovery market driver impact
  • Fig. 12 Global Artificial Intelligence in drug discovery market restraints impact
  • Fig. 13 Global Artificial Intelligence in drug discovery market - PESTLE analysis
  • Fig. 14 Global Artificial Intelligence in drug discovery market - Porter's Analysis
  • Fig. 15 Global Artificial Intelligence in drug discovery market - Application outlook and key takeaways
  • Fig. 16 Global Artificial Intelligence in drug discovery market - Application movement analysis
  • Fig. 17 Drug optimization and repurposing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Preclinical testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Global Artificial Intelligence in drug discovery market - Therapeutic area outlook and key takeaways
  • Fig. 21 Global Artificial Intelligence in drug discovery market - Therapeutic area movement analysis
  • Fig. 22 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Neurodegenerative Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Cardiovascular Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Metabolic Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Infectious Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Global Artificial Intelligence in drug discovery market - Regional outlook and key takeaways
  • Fig. 29 Global Artificial Intelligence in drug discovery market - Regional movement analysis
  • Fig. 30 North America Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.K. Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Spain Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 China Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Middle East & Africa Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53. South Africa Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 UAE Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Recent Developments & Impact Analysis, By Key Market Participants
  • Fig. 58 Company market position analysis, 2023
  • Fig. 59 Strategic alliance and deals analysis
目次
Product Code: GVR-4-68039-029-7

Artificial Intelligence In Drug Discovery Market Growth & Trends:

The global artificial intelligence in drug discovery market size was estimated at USD 9.1 billion in 2030, and is expected to expand at a CAGR of 29.7% from 2024 to 2030. It is expected to expand at a CAGR of 29.6% from 2023 to 2030. The pandemic has made the adoption of AI more widespread in the pharma industry. AI and its related platforms aim to enhance medical imaging and diagnostics, management of chronic diseases, and drug designing. The overall human hours spent would be far more in comparison to the AI system scanning the same data, which reduces overall cost and is a more feasible approach.

The drug optimization and repurposing application segment held the largest revenue share in 2022. AI platforms help in the identification of target proteins for drugs to determine adverse events and possible side effects the drug can have. Drug molecules can be repurposed to make them more effective and with minimum side effects. Portfolio drugs for a company can be altered and studied using AI platforms at a much faster pace so as to hasten new drug development.

The oncology therapeutic area segment accounted for the largest revenue share in 2022. The majority of the pharmaceutical companies are pairing up with AI start-ups to optimize their cancer research, which is still an unchartered territory and there is a lot to be discovered. AI systems can identify cancer much earlier than a regular scan would indicate to even a thoroughly trained radiologist. This, in turn, can increase life expectancy and can also help identify markers to be studied for cancer research and drug development. Patients can be prescribed treatments suited to their genetic composition.

North America dominated the market in 2022. Many tech companies are now investing their money and efforts toward the use of AI in pharmaceutical companies. Companies like IBM, Microsoft, and other tech giants have formed collaborations with research institutes for faster drug development and clinical trials for multiple indications. Developing countries are also finding cost-effective measures to implement AI technology for their drug development and disease understanding.

Artificial Intelligence In Drug Discovery Market Report Highlights:

  • The drug optimization and repurposing application segment dominated the market and accounted for a revenue share of over 53.9% in 2022
  • By therapeutic area, the oncology segment held the largest revenue share of over 23.4% in 2022. The infectious diseases segment is expected to register the fastest growth rate during the forecast period
  • Asia Pacific is expected to expand at the fastest CAGR from 2023 to 2030. This can be attributed to the increasing adoption of AI among the developing countries in this region as a means to understand diseases and aid drug discovery
  • North America led the market and accounted for a revenue share of over 58.0% in 2022. The U.S. is significantly contributing to the regional market growth as the country has been the forerunner in the artificial intelligence technology

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
    • 1.1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation
  • 1.4 Segment Share Calculation
  • 1.5 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Global Artificial Intelligence (AI) in Drug Discovery Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Artificial Intelligence (AI) in Drug Discovery Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
    • 3.2.4 Global Artificial Intelligence (AI) in Drug Discovery Market: Pestle Analysis
    • 3.2.5 Global Artificial Intelligence (AI) in Drug Discovery Market: Porter's Analysis

Chapter 4 Global Artificial Intelligence (AI) in Drug Discovery Market: Application Estimates & Trend Analysis

  • 4.1 Artificial Intelligence (AI) in Drug Discovery Market: Application Movement Analysis
  • 4.2 Drug Optimisation and Repurposing
    • 4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.3 Preclinical Testing
    • 4.3.1 Preclinical Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4 Other Applications
    • 4.4.1 Other Applications Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Global Artificial Intelligence (AI) in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1 Artificial Intelligence (AI) in Drug Discovery Market: Therapeutic Area Movement Analysis
  • 5.2 Oncology
    • 5.2.1 Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3 Neurodegenerative Diseases
    • 5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4 Cardiovascular Disease
    • 5.4.1 Cardiovascular Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Metabolic Diseases
    • 5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6 Infectious Disease
    • 5.6.1 Infectious Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7 Others
    • 5.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Global Artificial Intelligence (AI) in Drug Discovery Market: Regional Estimates & Trend Analysis

  • 6.1 Global Artificial Intelligence (AI) in Drug Discovery Market Movement Ananlysis, By region
  • 6.2 Global Artificial Intelligence (AI) in Drug Discovery Market Share, By region, 2021 & 2030
  • 6.3 North America
    • 6.3.1 North America Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 U.S.
      • 6.3.2.1 U.S. Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 Canada
      • 6.3.3.1 Canada Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 Mexico
      • 6.3.4.1 Mexico Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Europe
    • 6.4.1 Europe Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2 U.K.
      • 6.4.2.1 U.K. Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3 Germany
      • 6.4.3.1 Germany Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4 France
      • 6.4.4.1 France Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5 Spain
      • 6.4.5.1 Spain Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6 Italy
      • 6.4.6.1 Italy Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7 Denmark
      • 6.4.7.1 Denmark Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5 Asia Pacific
    • 6.5.1 Asia Pacific Artificial intelligence (AI) in drug discovery market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2 China
      • 6.5.2.1 China Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3 India
      • 6.5.3.1 India Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4 Japan
      • 6.5.4.1 Japan Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5 Australia
      • 6.5.5.1 Australia Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6 South Korea
      • 6.5.6.1 South Korea Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6 Latin America
    • 6.6.1 Latin America Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2 Brazil
      • 6.6.2.1 Brazil Artificial Intelligence (AI) in Drug Discovery Market
    • 6.6.3 Argentina
      • 6.6.3.1 Argentina Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7 MEA
    • 6.7.1 MEA Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2 South Africa
      • 6.7.2.1 South Africa Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3 Saudi Arabia
      • 6.7.3.1 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4 UAE
      • 6.7.4.1 UAE Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5 Kuwait
      • 6.7.5.1 Kuwait Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
  • 7.3. Competitive Dashboard & Company Market Position Analysis
    • 7.3.1 Synergy Analysis: Major Deals & Strategic Alliances
    • 7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators

Chapter 8 Competitive Landscape

  • 8.1 IBM
    • 8.1.1 Company Overview
    • 8.1.2 Finanacial Performance
    • 8.1.3 Offerings
    • 8.1.4 Strategic Initiatives
  • 8.2 Exscientia
    • 8.2.1 Company Overview
    • 8.2.2 Finanacial Performance
    • 8.2.3 Offerings
    • 8.2.4 Strategic Initiatives
  • 8.3 GNS Healthcare (In January 2023, the company Rebranded as Aitia)
    • 8.3.1 Company Overview
    • 8.3.2 Finanacial Performance
    • 8.3.3 Offerings
    • 8.3.4 Strategic Initiatives
  • 8.4 Google (DeepMind)
    • 8.4.1 Company Overview
    • 8.4.2 Finanacial Performance
    • 8.4.3 Offerings
    • 8.4.4 Strategic Initiatives
  • 8.5 BenevolentAI
    • 8.5.1 Company Overview
    • 8.5.2 Finanacial Performance
    • 8.5.3 Offerings
    • 8.5.4 Strategic Initiatives
  • 8.6 BioSymetrics, Inc
    • 8.6.1 Company Overview
    • 8.6.2 Finanacial Performance
    • 8.6.3 Offerings
    • 8.6.4 Strategic Initiatives
  • 8.7 Atomwise Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Finanacial Performance
    • 8.7.3 Offerings
    • 8.7.4 Strategic Initiatives
  • 8.8 Berg Health (In January 2023, BPGbio Inc. acquired Berg Health)
    • 8.8.1 Company Overview
    • 8.8.2 Finanacial Performance
    • 8.8.3 Offerings
    • 8.9.4 Strategic Initiatives
  • 8.10 insitro
    • 8.10.1 Company Overview
    • 8.10.2 Finanacial Performance
    • 8.10.3 Offerings
    • 8.10.4 Strategic Initiatives
  • 8.11 CYCLICA (In May 2023, CYCLICA acquired by Recursion)
    • 8.11.1 Company Overview
    • 8.11.2 Finanacial Performance
    • 8.11.3 Offerings
    • 8.11.4 Strategic Initiatives